Astrana Health Stock Surges After Earnings

Astrana Health's stock price surged after a strong earnings report revealed a nearly 35% jump in revenue and an increased full-year sales outlook of $3.2 billion, overshadowing a profit slip. Despite the volatility and being down nearly 7% for the year, long-term investors have seen solid growth, with a $1,000 investment five years ago now worth around $1,765. Hosted on Acast. See acast.com/privacy for more information.